AU2976897A - Multiple-unit type prolonged action drug preparation - Google Patents

Multiple-unit type prolonged action drug preparation

Info

Publication number
AU2976897A
AU2976897A AU29768/97A AU2976897A AU2976897A AU 2976897 A AU2976897 A AU 2976897A AU 29768/97 A AU29768/97 A AU 29768/97A AU 2976897 A AU2976897 A AU 2976897A AU 2976897 A AU2976897 A AU 2976897A
Authority
AU
Australia
Prior art keywords
unit type
drug preparation
prolonged action
action drug
type prolonged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29768/97A
Inventor
Yuzo Kimura
Masami Koike
Tadashi Mukai
Toshio Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU2976897A publication Critical patent/AU2976897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU29768/97A 1996-06-18 1997-05-29 Multiple-unit type prolonged action drug preparation Abandoned AU2976897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15671896 1996-06-18
JP8-156718 1996-06-18
PCT/JP1997/001836 WO1997048382A2 (en) 1996-06-18 1997-05-29 Multiple-unit type prolonged action drug preparation

Publications (1)

Publication Number Publication Date
AU2976897A true AU2976897A (en) 1998-01-07

Family

ID=15633827

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29768/97A Abandoned AU2976897A (en) 1996-06-18 1997-05-29 Multiple-unit type prolonged action drug preparation

Country Status (3)

Country Link
AU (1) AU2976897A (en)
ID (1) ID17125A (en)
WO (1) WO1997048382A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA67802C2 (en) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION
EG23951A (en) * 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
US20050186276A1 (en) * 2003-07-17 2005-08-25 Pfizer Inc Pharmaceutical formulations
WO2005023225A1 (en) * 2003-09-05 2005-03-17 Ranbaxy Laboratories Limited Cilostazol adsorbate
KR20080076440A (en) * 2007-02-16 2008-08-20 (주)아모레퍼시픽 Controlled release preparation containing cilostazol and process for the preparation thereof
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228410A (en) * 1984-04-26 1985-11-13 Otsuka Pharmaceut Co Ltd Long-acting drug preparation
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
ES2067920T3 (en) * 1990-01-08 1995-04-01 Otsuka Pharma Co Ltd TONIC FOR HAIR AND CONDITIONING COMPOSITION.

Also Published As

Publication number Publication date
WO1997048382A3 (en) 1998-02-19
WO1997048382A2 (en) 1997-12-24
ID17125A (en) 1997-12-04

Similar Documents

Publication Publication Date Title
AU9187598A (en) Oral preparation
AU3288897A (en) Chair construction
AU8495998A (en) Improved dosage units
AU6784598A (en) Medical plug
GB9715490D0 (en) Pharmaceutical preparation
AU2976897A (en) Multiple-unit type prolonged action drug preparation
EP0907644A4 (en) Pharmaceutical preparation
ZA982073B (en) Pharmaceutical preparation
AU6006898A (en) Skin preparation
AU4001297A (en) Capsule
AU7830498A (en) Instant yogurt preparation
AU1475595A (en) Pharmaceutical preparation
AU1688099A (en) Pharmaceutical preparation
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU8155898A (en) Human preprotachykinin b
AU1645599A (en) Human matrilin-3
AU9338498A (en) Chair
AU6832198A (en) Catalyst preparation
AU9034498A (en) Human nucleotide pyrophosphohydrolase
AU2350797A (en) Cosmetic preparation
AU2279800A (en) Pharmaceutical preparation
AU1042899A (en) Castor
AU4948297A (en) Pharmaceutical preparation
AUPP574298A0 (en) Pharmaceutical preparation
AU6387998A (en) Medicinal temporizer